HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dagmara W Wojkowska Selected Research

2-hexynyladenosine-5'-N-ethylcarboxamide

3/2021Adenosine Receptor Agonist HE-NECA Enhances Antithrombotic Activities of Cangrelor and Prasugrel in vivo by Decreasing of Fibrinogen Density in Thrombus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dagmara W Wojkowska Research Topics

Disease

1Hypotension (Low Blood Pressure)
03/2021
1Thrombosis (Thrombus)
03/2021
1Neoplasms (Cancer)
01/2020

Drug/Important Bio-Agent (IBA)

1Adenosine-5'-(N-ethylcarboxamide) (NECA)IBA
03/2021
12-hexynyladenosine-5'-N-ethylcarboxamideIBA
03/2021
1cangrelorIBA
03/2021
1Prasugrel HydrochlorideFDA Link
03/2021
1Fibrinogen (Factor I)FDA Link
03/2021
1Purinergic P1 Receptors (Adenosine Receptor)IBA
03/2021
1ferric chlorideIBA
03/2021
1Blocking AntibodiesIBA
01/2020